Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF® for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
Bonnet M, Gabillard D, Domoua S, Muzoora C, Messou E, Sovannarith S, Nguyen DB, Badje A, Juchet S, Bunnet D, Borand L, Natukunda N, Tran TH, Anglaret X, Laureillard D, Blanc FX; STATIS ANRS 12290 Trial Team. Bonnet M, et al. Among authors: badje a. Clin Infect Dis. 2023 Mar 8:ciad125. doi: 10.1093/cid/ciad125. Online ahead of print. Clin Infect Dis. 2023. PMID: 36883573
Community Health Workers. Reinforcement of an Outreach Strategy in Rural Areas Aimed at Improving the Integration of HIV, Tuberculosis and Malaria Prevention, Screening and Care Into the Health Systems. "Proxy-Santé" Study.
Moh DR, Bangali M, Coffie P, Badjé A, Paul AA, Msellati P. Moh DR, et al. Among authors: badje a. Front Public Health. 2022 Feb 24;10:801762. doi: 10.3389/fpubh.2022.801762. eCollection 2022. Front Public Health. 2022. PMID: 35284357 Free PMC article.
Virological failure and drug resistance in West African HIV-infected adults who started ART immediately or deferred ART initiation.
Gabillard D, N'Takpé JB, Chaix ML, Kouame GM, Moh R, Toni TD, Le Carrou J, Karcher S, Badje A, Emieme A, Menan H, Danel C, Anglaret X, Eholié SP; Temprano ANRS 12136 study group. Gabillard D, et al. Among authors: badje a. J Antimicrob Chemother. 2021 Sep 15;76(10):2666-2674. doi: 10.1093/jac/dkab225. J Antimicrob Chemother. 2021. PMID: 34533197 Clinical Trial.
Elite and viremic HIV-1 controllers in West Africa.
N'takpé JB, Gabillard D, Moh R, Gardiennet E, Toni TD, Kouame GM, Badje A, Emieme A, Karcher S, Le Carrou J, Ménan H, Danel C, Eholie SP, Rouzioux C, Anglaret X, Lambotte O. N'takpé JB, et al. Among authors: badje a. AIDS. 2022 Jan 1;36(1):29-38. doi: 10.1097/QAD.0000000000003072. AIDS. 2022. PMID: 34524145 Free PMC article. Clinical Trial.
Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data.
Ross JM, Badje A, Rangaka MX, Walker AS, Shapiro AE, Thomas KK, Anglaret X, Eholie S, Gabillard D, Boulle A, Maartens G, Wilkinson RJ, Ford N, Golub JE, Williams BG, Barnabas RV. Ross JM, et al. Among authors: badje a. Lancet HIV. 2021 Jan;8(1):e8-e15. doi: 10.1016/S2352-3018(20)30299-X. Lancet HIV. 2021. PMID: 33387480 Free PMC article.
Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4+ cell counts.
Kouamé GM, Gabillard D, Moh R, Badje A, Ntakpé JB, Emième A, Maylin S, Toni TD, Ménan H, Zoulim F, Danel C, Anglaret X, Eholié S, Lacombe K, Boyd A. Kouamé GM, et al. Among authors: badje a. Antivir Ther. 2021 Jan-Feb;26(1-2):25-33. doi: 10.1177/13596535211039589. Epub 2021 Sep 4. Antivir Ther. 2021. PMID: 35485344 Clinical Trial.
28 results